novo nordisk glp 1 drug asks FDA to prevent compounders from making GLP-1 knockoffs GLP-1 Drug Prescriptions Have Doubled

Overall diet quality The research suggests many patients on GLP-1 therapy are eating poorly even before starting the medication, putting them at risk for deficiency even more

Risk of retinal vein occlusion between GLP-1 receptor agonists and DPP-4 inhibitors in type 2 diabetes: a retrospective cohort study

Leaner users should focus on body composition analysis and measurements in specific areas rather than scale weight, as changes may be subtle but meaningful for achieving very lean physiques or addressing final stubborn deposits

There is still a need for further improvement in our understanding of the molecular mechanisms underlying endothelial dysfunction, platelet hyperactivity, high blood pressure, and vascular damage

For instance, Gu et al